Stop TB Partnership

The Coordinating Board

The Stop TB Partnership Coordinating Board provides leadership and direction, monitors the implementation of agreed policies, plans and activities of the Partnership, and ensures coordination among Stop TB Partnership components.

The Stop TB Partnership is governed by the Coordinating Board, supported by two standing board committees, the Executive Committee and the Finance Committee.

Board Role

The Stop TB Partnership Board has a responsibility: a) to the global TB community to build awareness, facilitate consensus on strategy, and identify key strategic issues affecting TB; and b) to the Secretariat to set strategic direction, provide oversight and guidance, and approve budgets.

To fulfill this dual role, the Board has the following specific responsibilities:

  • Provide overall strategic direction for the Partnership to address TB as a public health threat
  • Approve the Global Plan to Stop TB, the Secretariat Operational Strategy, and the Secretariat budget
  • Review the Secretariat annual budget against the Operational Strategy
  • Monitor the performance of the Operational Strategy and work plan against a set of approved metrics
  • Make recommendations regarding the recruitment of the Executive Secretary, conduct an annual performance assessment process, and if required, make recommendations to the host organization regarding the termination of the Executive Secretary’s contract
  • Establish the overall principles and direction for the governing, administrative, and advisory bodies of the Board and any additional Board structures (e.g. task-forces, sub-committees)
  • Elect the Board Chair, Vice-Chair, and Finance Committee Chair through transparent selection processes
  • Oversee the effectiveness and efficiency of the governance model, including amending the composition of the Board, creating or terminating structures, and reviewing/adjusting governance policies as necessary
  • Establish and oversee the strategy for identifying and managing risks, particularly strategic, reputational, and operational risks
  • Influence other actors in the global health community to promote the TB agenda and mobilize resources for TB
  • Provide a platform for all TB voices to be heard

Board Composition

The Board is composed of the following (constituency seats are designated with a *):

  • Three representatives of financial donors,
  • One representative of Foundations,
  • Technical Agencies (two seats shared amongst CDC, the Union, and KNCV),
  • Four representatives of multilaterals, one each from WHO, The World Bank and The Global Fund to Fight AIDS, Tuberculosis and Malaria and one UN agency,
  • One representative of developing country NGO*,
  • One representative of developed country NGO*,
  • One representative of the private sector*,
  • Two representatives from TB Affected Communities*,
  • Two representatives of Working Groups* (one from Research Working Groups and one from Implementation Working Groups),
  • Six representatives from TB Affected Countries
  • Two open seats

Additionally there are the following non-voting seats on the Board:

  • Board Chair
  • Vice-Chair
  • UNITAID